Story · Medicine & Biotech

Teva expands biosimilars alliance with Samsung Bioepis

1 outlet · first reported by PharmaTimes 2d ago

Coverage, in order

  1. 2d ago
    PharmaTimes UK indie
    Teva expands biosimilars alliance with Samsung Bioepis

    Agreement covers two FDA-approved immunology treatments

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.